Immunotherapy Potentiates the Effect of Chemotherapy in Metastatic Melanoma—A Retrospective Study

Melanoma survival increased with targeted- and immunotherapy agents, yet most patients ultimately progress and require salvage therapy. In our experience, some progressive disease patients on immune-checkpoint inhibitors (ICIs) demonstrate deep and sustained responses to chemotherapy. We hypothesize...

Descripción completa

Detalles Bibliográficos

Autores principales:	Reut Hadash-Bengad, Emma Hajaj, Shiri Klein, Sharon Merims, Stephen Frank, Galit Eisenberg, Alexander Yakobson, Marina Orevi, Nadia Caplan, Tamar Peretz, Michal Lotem, Jonatan E. Cohen
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Frontiers Media S.A. 2020-02-01
Colección:	Frontiers in Oncology
Materias:	immune checkpoint inhibitors malignant melanoma chemotherapy salvage therapy immune-monitoring
Acceso en línea:	https://www.frontiersin.org/article/10.3389/fonc.2020.00070/full
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!